China’s State FDA Approves Botox For Wrinkles
This article was originally published in PharmAsia News
Executive Summary
China's State FDA approved Botox (botulinum toxin type A) for removing frown lines in plastic surgery and dermatology departments of hospitals in cities such as Beijing, Shanghai and Guangzhou. Botox comes under toxic controlled drugs (PharmAsia News, July 30, 2008) and can only be used under very strict prescriptive regulation. In addition, SFDA imposes stringent restrictions on the drug, such as administration under the supervision of physicians with prescription rights, and the banning of its sales by drugstores and beauty salons. Although many of China's cosmetic hospitals have widely used botulinum toxin in wrinkle removal and face slimming for years, the practice is deemed illegal without SFDA's approval. (Click here for more - Chinese language)